Cryoport Continues its Expansion in the European Market with Tec4med Lifescience GmbH Acquisition

Tec4med is happy to share that Cryoport, Inc. (NASDAQ: CYRX), a leading global provider of innovative products and services to the fast-growing cell and gene therapy industry, has announced the acquisition of Tec4med LifeScience GmbH (“Tec4med”), a solution provider and innovation leader in the pharmaceutical supply chain visibility, condition monitoring and temperature-controlled packaging space (read the official press release here).

The whole Tec4med and Cryoport team is looking forward to this strong partnership to further build on our high quality, integrity, and service standards in the field of NextGen of supply chain visibility solutions.